Загрузка...
Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris(®)) in Pituitary-Suppressed Healthy Women
This was a Phase I, open-label, randomized, two-period, two-sequence crossover study [ClinicalTrials.gov NCT02317809 (https://www.clinicaltrials.gov/ct2/show/NCT02317809); EudraCT 2014-003506-32] assessing the bioequivalence of the liquid and freeze-dried formulations of fixed-dose, fixed-ratio (2:1...
Сохранить в:
| Опубликовано в: : | Front Endocrinol (Lausanne) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768635/ https://ncbi.nlm.nih.gov/pubmed/29375477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00371 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|